T4-like phage Bp7, a potential antimicrobial agent for controlling drug-resistant Escherichia coli in chickens
- PMID: 23835183
- PMCID: PMC3754183
- DOI: 10.1128/AEM.01505-13
T4-like phage Bp7, a potential antimicrobial agent for controlling drug-resistant Escherichia coli in chickens
Abstract
Chicken-pathogenic Escherichia coli is severely endangering the poultry industry in China and worldwide, and antibiotic therapy is facing an increasing problem of antibiotic resistance. Bacteriophages can kill bacteria with no known activity in human or animal cells, making them an attractive alternative to antibiotics. In this study, we present the characteristics of a novel virulent bacteriophage, Bp7, specifically infecting pathogenic multidrug-resistant E. coli. Phage Bp7 was isolated from chicken feces. Bp7 belongs to the family Myoviridae, possessing an elongated icosahedral head and contractile sheathed tail. It has a 168-kb double-stranded DNA genome. For larger yields, its optimal multiplicity of infection (MOI) to infect E. coli was about 0.001. The latent period was 10 to 15 min, and the burst size was 90 PFU/infected cell. It was stable both at pH 5.0 to 10.0 and at 40°C or 50°C for at least 1 h. Bp7 could infect 46% of pathogenic clinical E. coli strains. Bp7 harbored 791 open reading frames (ORFs) and 263 possible genes. Among the 263 genes, 199 possessed amino acid sequence identities with ORFs of phage T4, 62 had identities with other T4-like phages, and only one lacked any database match. The genome of Bp7 manifested obvious division and rearrangement compared to phages T4, JS98, and IME08. Bp7 is a new member of the "T4-like" genus, family Myoviridae. Its wide host range, strong cell-killing activity, and high stability to pH make it an alternative to antimicrobials for controlling drug-resistant E. coli in chickens.
Figures
Similar articles
-
Isolation and Characterization of Lytic Phage vB_EcoM_JS09 against Clinically Isolated Antibiotic-Resistant Avian Pathogenic Escherichia coli and Enterotoxigenic Escherichia coli.Intervirology. 2015;58(4):218-31. doi: 10.1159/000437426. Epub 2015 Aug 26. Intervirology. 2015. PMID: 26337345
-
Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates.BMC Microbiol. 2012 Jul 28;12:156. doi: 10.1186/1471-2180-12-156. BMC Microbiol. 2012. PMID: 22838726 Free PMC article.
-
Isolation and characterization of a T4-like phage with a relatively wide host range within Escherichia coli.J Basic Microbiol. 2016 Apr;56(4):405-21. doi: 10.1002/jobm.201500440. Epub 2015 Dec 23. J Basic Microbiol. 2016. PMID: 26697952
-
Genome sequencing and analysis of an Escherichia coli phage vB_EcoM-ep3 with a novel lysin, Lysep3.Virus Genes. 2015 Jun;50(3):487-97. doi: 10.1007/s11262-015-1195-8. Epub 2015 Apr 5. Virus Genes. 2015. PMID: 25842152
-
Functional characterization of a novel lytic phage EcSw isolated from Sus scrofa domesticus and its potential for phage therapy.Mol Cell Probes. 2015 Jun;29(3):151-7. doi: 10.1016/j.mcp.2015.03.004. Epub 2015 Mar 21. Mol Cell Probes. 2015. PMID: 25805216
Cited by
-
Development of a Replication-Deficient Bacteriophage Reporter Lacking an Essential Baseplate Wedge Subunit.Viruses. 2023 Dec 20;16(1):8. doi: 10.3390/v16010008. Viruses. 2023. PMID: 38275943 Free PMC article.
-
Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.Appl Environ Microbiol. 2023 Jul 26;89(7):e0058123. doi: 10.1128/aem.00581-23. Epub 2023 Jun 20. Appl Environ Microbiol. 2023. PMID: 37338346 Free PMC article.
-
Characterization of a lytic Pseudomonas aeruginosa phage vB_PaeP_ASP23 and functional analysis of its lysin LysASP and holin HolASP.Front Microbiol. 2023 Mar 15;14:1093668. doi: 10.3389/fmicb.2023.1093668. eCollection 2023. Front Microbiol. 2023. PMID: 36998407 Free PMC article.
-
Characterization of a lytic Escherichia coli phage CE1 and its potential use in therapy against avian pathogenic Escherichia coli infections.Front Microbiol. 2023 Feb 16;14:1091442. doi: 10.3389/fmicb.2023.1091442. eCollection 2023. Front Microbiol. 2023. PMID: 36876110 Free PMC article.
-
Dietary coated essential oil and organic acid mixture supplementation improves health of broilers infected with avian pathogenic Escherichia coli.Anim Nutr. 2022 Oct 11;12:245-262. doi: 10.1016/j.aninu.2022.09.010. eCollection 2023 Mar. Anim Nutr. 2022. PMID: 36712401 Free PMC article.
References
-
- Olsen RH, Frantzen C, Christensen H, Bisgaard M. 2012. An investigation on first-week mortality in layers. Avian Dis. 56:51–57 - PubMed
-
- Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, Huang DB, Dupont MW, Adachi JA, De La Cabada FJ, Taylor DN, Jaini S, Martinez Sandoval F. 2007. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin. Gastroenterol. Hepatol. 5:451–456 - PubMed
-
- Merson MH, Sack RB, Islam S, Saklayen G, Huda N, Huq I, Zulich AW, Yolken RH, Kapikian AZ. 1980. Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: clinical aspects and a controlled trial of tetracycline. J. Infect. Dis. 141:702–711 - PubMed
-
- Zhang T, Wang CG, Lv JC, Wang RS, Zhong XH. 2012. Survey on tetracycline resistance and antibiotic-resistant genotype of avian Escherichia coli in North China. Poult. Sci. 91:2774–2777 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
